Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07601737
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell CarcinomaShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruitingPhase 2
NCT07601737Recruiting
Phase 2
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of L...Shanghai General Hospital...
NCT07602530
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical PracticeAstellas Pharma Europe Ltd.Recruiting
NCT07602530Recruiting
—
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezoline...Astellas Pharma Europe Lt...
NCT07601815
MEST : A School- Based Health Literacy Intervention TrialNorwegian Institute of Public HealthNot Yet RecruitingNot Applicable
NCT07601815Not Yet Recruiting
Not Applicable
MEST : A School- Based Health Literacy Intervention TrialNorwegian Institute of Pu...
NCT07604961
Short-Term Inspiratory Muscle Training and Aerobic Exercise in Women With COPDMehmet İsmail TOSUNCompletedNot Applicable
NCT07604961Completed
Not Applicable
Short-Term Inspiratory Muscle Training and Aerobic Exercise in Women With COPDMehmet İsmail TOSUN
NCT07601997
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study)Myomed Technology (Shaoxing) Co., Ltd.Not Yet RecruitingNot Applicable
NCT07601997Not Yet Recruiting
Not Applicable
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reper...Myomed Technology (Shaoxi...
NCT07603050
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in Patients With Type III Gaucher's DiseaseShanghai Vitalgen BioPharma Co., Ltd.Not Yet RecruitingPhase 1
NCT07603050Not Yet Recruiting
Phase 1
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in P...Shanghai Vitalgen BioPhar...
NCT07602426
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of resO™ Bone and Joint Support Postbiotic on Physical Function, Pain Interference, and Mobility in Adults With Joint DiscomfortAble Biolabs, LLCActive Not RecruitingNot Applicable
NCT07602426Active Not Recruiting
Not Applicable
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of...Able Biolabs, LLC
NCT07603193
Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib CreamICON Clinical ResearchEnrolling By Invitation
NCT07603193Enrolling By Invitation
—
Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment W...ICON Clinical Research
NCT07603843
Use of Cognitive Aid Methods in the Management of Status EpilepticusAnkara UniversityNot Yet RecruitingNot Applicable
NCT07603843Not Yet Recruiting
Not Applicable
Use of Cognitive Aid Methods in the Management of Status EpilepticusAnkara University
NCT07604142
Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant PlacementTanta UniversityEnrolling By InvitationNot Applicable
NCT07604142Enrolling By Invitation
Not Applicable
Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant...Tanta University
NCT07600866
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan CohortNucleo Research, Inc.Not Yet Recruiting
NCT07600866Not Yet Recruiting
—
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Sc...Nucleo Research, Inc.
NCT07605234
Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Photobiomodulation as an Adjunct to Standard Supportive Care for Chemotherapy Induced Oral Mucositis in Pediatric Patients With Hematolymphoid MalignanciesTata Memorial HospitalNot Yet RecruitingNot Applicable
NCT07605234Not Yet Recruiting
Not Applicable
Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Ph...Tata Memorial Hospital
NCT07604038
Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived Mycolicibacterium) for Stress, Sleep, and InflammationKioga Inc.CompletedNot Applicable
NCT07604038Completed
Not Applicable
Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived...Kioga Inc.
NCT07603297
Identifying Essential Elements of SAP SupportsChildren's Hospital Medical Center, CincinnatiCompletedNot Applicable
NCT07603297Completed
Not Applicable
Identifying Essential Elements of SAP SupportsChildren's Hospital Medic...
NCT07604623
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Cardiac SurgeryUniversity of AlbertaNot Yet RecruitingNot Applicable
NCT07604623Not Yet Recruiting
Not Applicable
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Ca...University of Alberta
NCT07604025
Senna vs. Polyethylene Glycol 3350 for the Treatment of Retentive Encopresis in Children: a Randomized, Double-blinded, StudyAssaf-Harofeh Medical CenterNot Yet RecruitingEarly Phase 1
NCT07604025Not Yet Recruiting
Early Phase 1
Senna vs. Polyethylene Glycol 3350 for the Treatment of Retentive Encopresis in...Assaf-Harofeh Medical Cen...
NCT07603934
The Effect of Different Intra-canal Medications on Postoperative PainCairo UniversityRecruitingEarly Phase 1
NCT07603934Recruiting
Early Phase 1
The Effect of Different Intra-canal Medications on Postoperative PainCairo University
NCT07602699
Multi-Site Trial of Tirzepatide for Smoking CessationNational Institute on Drug Abuse (NIDA)RecruitingPhase 2
NCT07602699Recruiting
Phase 2
Multi-Site Trial of Tirzepatide for Smoking CessationNational Institute on Dru...
NCT07603765
Minimally Invasive Hemodynamic Monitoring in Cardiac AblationIstanbul University - CerrahpasaRecruiting
NCT07603765Recruiting
—
Minimally Invasive Hemodynamic Monitoring in Cardiac AblationIstanbul University - Cer...
Result Breakdown
Not yet recruiting9 (45%)
Recruiting5 (25%)
Completed3 (15%)
Enrolling by invitation2 (10%)
Active, not recruiting1 (5%)
not_applicable11 (55%)
Not Specified4 (20%)
Phase 22 (10%)
Early Phase 12 (10%)
Phase 11 (5%)